Slow FDA approvals of at-home rapid tests have prolonged the pandemic

The Washington Examiner | Sally C. Pipes
September 18, 2021

These regulatory delays deserve some blame for our current shortage of rapid tests. Many stores and online retailers are sold out. The tests that are in stock are considerably more expensive in the States. The popular BinaxNOW test made by Abbott costs about $24 per two-pack in America. In Germany, rapid tests are about $1 a piece , according to Kaiser Health News.

Read more. . .

Another Warning About Medicare Is Going Unheeded

Genetic Literacy Center | Henry Miller, M.S., M.D.
September 14, 2021

The operative concept for managing the pandemic, or any medical problem, for that matter, can be summarized in a single phrase: minimizing the probability of adverse outcomes. But we, as individuals, public health officials and political leaders have widely differing tolerance for risks. And the risk-related circumstances vary widely in different states and localities; one size doesn’t fit all.

Read more. . .

Biden’s Prescription Drug Plan Is Nothing More Than Price Controls

Newsmax | Sally C. Pipes
September 16, 2021

The Biden administration’s plan doesn’t include the words “price controls.” It calls them “negotiations.” The administration implores Congress to permit the Secretary of Health and Human Services to negotiate the prices of drugs dispensed through Medicare Parts B and D directly with manufacturers.
Drug companies can’t “negotiate” on equal footing with the federal government.

Read more. . .